KVÅKVÅ3E03316 — Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous
KVÅKVÅ3E033VH — Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach
KVÅKVÅ3E04316 — Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous
KVÅKVÅ3E043VH — Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach
KVÅKVÅ3E050VH — Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach
KVÅKVÅ3E05316 — Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous
KVÅKVÅ3E053VH — Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach
KVÅKVÅ3E06316 — Introduction of Recombinant Human-activated Protein C into Central Artery, Percutaneous
KVÅKVÅ3E063VH — Introduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach
KVÅKVÅ3E07316 — Introduction of Recombinant Human-activated Protein C into Coronary Artery, Percutaneous
KVÅKVÅC9354 — Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter
